Molecular characterization of the response to conventional chemotherapeutics in Pro-B-ALL cell lines in terms of tumor relapse

enthalten in: Genes | 14 July 2022

von Gladbach, Y. | Sklarz, L. | Roolf, C. | +6

Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines

enthalten in: Cancer cell international | 12 August 2020

von Sklarz, L. | Gladbach, Y. | Ernst, M. | +10

In vivo vaccination with cell line-derived whole tumor lysates : neoantigen quality, not quantity matters

enthalten in: Journal of translational medicine | 21 October 2020

von Salewski, I. | Gladbach, Y. | Kuntoff, S. | +4

Tackling precision oncology using heterogeneous omics data sets

Erschienen: Dissertation, Ruperto Carola University Heidelberg, 2020

von Gladbach, Y. | Brors, B.

Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia

Erschienen: London, Berlin, 10 Mai 2019

von Richter, A. | Roolf, C. | Hamed, M. | +9